Comparative Effectiveness Research & Cochrane Eyes and Vision (CEV)

比较效果研究

• 批准号: 9208291
• 负责人: KAY DICKERSIN
• 金额: $ 99.98万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9208291
• 关键词: Academic Medical Centers; Achievement; Address; Blindness; Caring; Clinical; Clinical Practice Guideline; Collaborations; Communities; Development; Diagnosis; E-learning; Education; Educational workshop; Ensure; Equilibrium; Evidence based intervention; Eye; Foundations; Funding; Generations; Goals; Guidelines; Health; Health Professional; Healthcare; Individual; Influentials; Institute of Medicine (U.S.); International; Intervention; Journals; Knowledge; Lead; Leadership; Learning; Link; Manuals; Medical center; Meta-Analysis; Methodology; Methods; Modeling; Monitor; National Eye Institute; Ophthalmologist; Optometrist; Outcome; Patients; Persons; Policy Maker; Positioning Attribute; Prevention; Printed Media; Procedures; Production; Professional Organizations; Publications; Publishing; Recommendation; Research; Research Methodology; Research Personnel; Risk; Role; Slide; Societies; Students; Time; United States; Update; Vision; Visual impairment; Work; care delivery; clinical practice; comparative effectiveness; compare effectiveness; design; effectiveness research; evidence base; evidence based guidelines; experience; flexibility; health training; improved; innovation; massive open online courses; medical specialties; meetings; organizational structure; prevent; programs; research study; social media; success; symposium; systematic review; vision science

PROEJCT SUMMARY/ABSTRACT Systematic reviews are comparative effectiveness research (CER) studies that use explicit methods to identify, appraise, and synthesize available evidence for a clinical question. Cochrane is the only international organization that has the goal of synthesizing and keeping up-to-date the evidence for all of healthcare. Cochrane Eyes and Vision (CEV) aims to prepare and promote access to systematic reviews of interventions used to prevent or treat eye conditions and/or visual impairment, and to help people adjust to visual impairment or blindness. For 12 years, CEV United States Satellite (CEV@US) has overseen production of systematic reviews and contributed to CER in eyes and vision in the US. The CEV@US's organizational structure comprises an engaged Advisory Board, a leadership team consisting of the PI and two senior Co-Investigators, and five interdependent workgroups who implement the five Specific Aims with stakeholder partners. CEV@US is in a unique position to make a much-needed, continued contribution to well-informed decisions about vision care, leading to real impact to preserving sight and prevention of blindness. Our objective is for CEV@US to continue to serve as the center for CER in eyes and vision in the US. In Aim 1, we will build a CER workforce within the field of vision science by educating health professionals. Our education is flexible and tailored, and is offered online and in-person, via professional organizations, clinical programs, and one-time workshops. In Aim 2, we will partner with individual (eg, clinicians, patients) and organizational (eg, professional and specialty societies, academic medical centers, journals) stakeholders to ensure that the knowledge underpinning clinical practice is reliable, available, and applied. Our partnership strategy is multidimensional, unique and extensive, and offers a methodologic hub supporting clinician-authors and researchers. In Aim 3: we will prepare systematic reviews that address prioritized questions in collaboration with clinicians and methodologists, publish the reviews, and regularly update them as new research emerges. We will work directly with clinicians and apply state-of-art methods in producing these reviews. In Aim 4, we will conduct foundational methodologic research related to systematic reviews, and influence the field of evidence synthesis. In Aim 5, we will disseminate the results of our research extensively. Our dissemination strategy is designed to having an impact, using traditional and electronic means. All aims taken together, our approach will leverage the collective expertise and perspectives of our stakeholder partners and lead the effort to build a CER community.

项目概要/摘要 系统评价是比较有效性研究（CER），使用明确的方法来识别， 评估和综合临床问题的可用证据。科克伦是唯一一个 该组织的目标是综合和保持最新的证据，为所有的医疗保健。 科克伦眼科和视力（CEV）旨在准备和促进获得干预措施的系统评价 用于预防或治疗眼部疾病和/或视力障碍，并帮助人们适应视力障碍 或者失明12年来，CEV美国卫星（CEV@US）一直监督系统的生产， 审查并为美国眼部和视力的CER做出贡献。 CEV@US的组织结构包括一个参与咨询委员会，一个领导团队， 由PI和两名高级合作研究者组成，以及五个相互依存的工作组， 与利益相关方合作的五个具体目标。CEV@US处于一个独特的位置，可以提供急需的， 继续为视力保健做出明智的决定，对视力保护产生真实的影响 和预防失明。 我们的目标是CEV@US继续作为美国眼科和视力CER的中心。在Aim中 1、通过教育健康专业人员，在视觉科学领域建立CER劳动力队伍。我们 教育是灵活的，量身定制的，并通过专业组织，临床 项目和一次性研讨会。在目标2中，我们将与个人（如临床医生、患者）合作， 组织利益相关者（例如，专业和专业协会、学术医疗中心、期刊）， 确保支撑临床实践的知识是可靠的、可用的和应用的。我们的伙伴关系 战略是多维的，独特的和广泛的，并提供了一个方法论枢纽支持临床医生，作者 和研究人员。在目标3中：我们将准备系统性综述，解决以下优先问题： 与临床医生和方法学家合作，发表评论，并定期更新为新的 研究出现。我们将直接与临床医生合作，并应用最先进的方法来生产这些产品。 评论.在目标4中，我们将进行与系统评价相关的基础方法学研究， 影响证据合成领域。在目标5中，我们将广泛传播我们的研究成果。 我们的传播战略旨在利用传统和电子手段产生影响。区域所有 总的来说，我们的方法将利用我们的利益相关者伙伴的集体专业知识和观点 并领导建立CER社区的努力。